From: A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity
CNS pathology | BBB dysfunction |
---|---|
Stroke | Astrocytes secrete transforming growth factor-β (TGFβ), which downregulates brain capillary endothelial Expression of fibrinolytic enzyme tissue Plasminogen activator (tPA) and anticoagulant thrombomodulin (TM) Proteolysis of vascular basement membrane/matrix Induction of aquaporin 4 (AQP4) mRNA and protein at BBB disruption |
Trauma | Bradykinin (an inflammatory mediator) stimulates the production and the release of interleukin-6 (IL-6) from astrocytes, leading to the opening of the BBB |
Infectious or inflammatory processes | e.g., bacterial infections, meningitis, encephalitis, and sepsis The bacterial protein lipopolysaccharide (LPS) affects the permeability of BBB tight junctions. This is mediated by the production of free radicals, IL-6, and IL-1 β Interferon-β prevents BBB disruption Alterations in P-glycoprotein expression and activity in the BBB Increased pinocytosis in brain microvessel endothelium and swelling of astrocytes end-feet |
Multiple sclerosis | Breakdown of the BBB Tight junction abnormalities Downregulation of laminin in the basement membrane Selective loss of claudin3 in experimental autoimmune encephalomyelitis |
HIV | BBB tight junction disruption Cytokines secretion by activated macrophages and astrocytes, e.g., TNF-α, NO, platelet-activating factor, and quinolinic acid |
Alzheimer’s disease | Decreased glucose transport, downregulation of glucose transporter GLUT1, altered agrin levels, upregulation of AQP4 expression Accumulation of amyloid-β, a key neuropathological feature of Alzheimer’s disease, by decreased levels of P-glycoprotein transporter expression Altered cellular relations at the BBB, and changes in the basal lamina and amyloid-β clearance |
Parkinson’s disease | Dysfunction of the BBB by reduced efficacy of P-glycoprotein |
Epilepsy | Transient BBB opening in epileptogenic foci, and upregulated expression of P-glycoprotein and other drug efflux transporters in astrocytes and endothelium |
Brain tumors | Breakdown of the BBB Downregulation of tight junction protein claudin 1, 3, and occludin; redistribution of astrocyte AQP4 and Kir4.1 (inwardly rectifying K+ channel) |
Pain | Inflammatory pain alters BBB tight junction protein expression and BBB permeability |
Glaucoma | Opening of the BBB, possibly through the diffusion of endothelin-1 and matrix-metalloproteinase-9 into peri-capillary tissue |
Lysosomal storage diseases (LSD) | May show changes in BBB permeability, and/or transport, depending on specific LSD |